Paper Details
- Home
- Paper Details
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review.
Author: CrowtherMark, CukerAdam, GarciaDavid A, SamuelsonBethany T, SiegalDeborah M
Original Abstract of the Article :
Direct oral anticoagulants (DOACs) are the treatment of choice for most patients with atrial fibrillation and/or noncancer-associated venous thromboembolic disease. Although routine monitoring of these agents is not required, assessment of anticoagulant effect may be desirable in special situations....See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310120/
データ提供:米国国立医学図書館(NLM)
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants
Think of the blood as a river flowing through the body. This research delves into the world of direct oral anticoagulants (DOACs), a group of medications that help thin the blood and prevent clots, like strategically placed dams along the river, to ensure smooth and safe blood flow. The research reviewed studies that investigated how well laboratory tests can measure the effectiveness of these medications. It's like having a map to guide us as we navigate the intricate landscape of blood clotting and its management.
Monitoring Anticoagulation: A Balancing Act
While routine monitoring of these medications is not always necessary, the research suggests that there are situations where laboratory assessments are valuable, like when we need to ensure the dams are functioning correctly. This is particularly important for patients with atrial fibrillation or non-cancer-associated venous thromboembolic disease, conditions that put them at risk for blood clots. Understanding the effectiveness of these medications is like knowing the depth of the river, allowing us to make informed decisions about their use.
A Safer Journey Through the Bloodstream
By carefully monitoring the anticoagulant effects of DOACs, we can ensure that patients are receiving the right dose and that their risk of both bleeding and clotting is minimized. This is like navigating a treacherous desert, knowing the best routes and avoiding potential dangers. This research helps us better understand the intricate landscape of blood clotting, paving the way for safer and more effective treatments.
Dr. Camel's Conclusion
This study sheds light on the delicate balance of managing blood clotting with DOACs. It's like navigating a desert, knowing the right amount of water and avoiding both dehydration and flooding. By understanding how to monitor these medications, we can ensure a safer journey through the bloodstream.
Date :
- Date Completed 2017-05-12
- Date Revised 2022-03-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.